Cagle Paul J MD

Cagle Paul J MD, a sole proprietorship medical practice based in New York, provides medical expert case review and expert witness services to the federal government as a prime contractor on 100 percent of recent awards, competing entirely under set-aside and full-and-open vehicles designated for small business work.

The vendor operates exclusively within two federal customer agencies. The Health Resources and Services Administration (HRSA) Headquarters accounts for 95 awards valued at $15.8 million in combined potential value, with all work supporting the Vaccine Injury Compensation Program (VICP) and Countermeasures Injury Compensation Program (CICP). The Department of Justice Civil Division places the remaining 5 awards valued at $30 thousand for expert witness services. HRSA's dominance reflects the vendor's specialized role in federal vaccine-injury claim adjudication.

Dr. Cagle's work consists entirely of medical case review, expert medical opinions, and expert testimony services. Representative HRSA awards under the VICP include a $37,500 total small business set-aside BPA call awarded August 25, 2026 for medical case reviewer services with completion by July 24, 2027; a $24,375 total small business set-aside BPA call awarded April 30, 2026 for vaccine injury and countermeasures injury compensation program case analysis; and a $18,750 total small business set-aside BPA call awarded September 19, 2025 for medical case reviewer services. For the Department of Justice, the vendor provided expert witness services under purchase orders valued at $3,750 (awarded February 21, 2025, completion through February 20, 2028) and earlier expert witness calls of $7,500 and $6,000.

The vendor holds two active BPA vehicles with HRSA. The primary vehicle is a newly awarded single-award BPA valued at $7.5 million with a ceiling running through May 14, 2031, awarded May 15, 2026, for VICP and CICP medical expert consulting. This replaced a prior single-award BPA valued at $249,999 (expiring May 2026) under which HRSA issued over a dozen call orders ranging from $600 to $18,750. Against the older BPA vehicle 75R60221A00038, the vendor has received 58 task orders carrying $393 thousand in combined potential value; against BPA 75R60218A00027, 32 task orders worth $102 thousand.

Activity has declined from 14 awards in 2022 to 6 in 2026 year-to-date. This trajectory reflects consolidation of vendor work under the new $7.5 million BPA, which replaced the older $249,999 vehicle and shifts the contracting structure from numerous small calls to a larger indefinite-delivery framework. Six awards with ultimate completion in the next twenty-four months carry $121 thousand in combined potential value, representing a modest recompete exposure relative to the new BPA's capacity. The vendor's professional category is 98 awards under NAICS 541110 (Offices of Physicians except Mental Health Specialists), with 100 percent of awards classified under PSC Support-Professional: Expert Witness.